Brazil Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis The Brazil Cell and Gene Therapy Manufacturing QC Market was valued at USD 47.33 Million in 2024 and is projected to reach USD 108.35 Million by 2028, expanding at a CAGR of 23.1% during the forecast period. The market growth is primarily driven by the healthcare, biotechnology, and pharmaceutical industries. With a surge in the use of personalized medicine and gene editing tools in Brazil, the demand for quality control in cell and gene therapy manufacturing has swelled. Technological advancements such as CRISPR technology and Next-Generation Sequencing (NGS) offer potential opportunities for this market. Moreover, Brazil's export potential in gene therapy products signifies growth opportunities. With these strategies and advancements, Brazil is tactically positioning itself as a key player in the Cell and Gene Therapy Manufacturing QC Market in Latin America.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market Highlights
- Cell Therapy held the leading position among Therapy Type segments in 2024, based on market size.
- Gene Therapy is projected to post the fastest growth rate, sustaining its position as the most attractive Therapy Type segment during the forecast horizon.
- Brazil contributed 2.12% to the global cell and gene therapy manufacturing qc market size in 2024.
- By 2028, United States is forecasted to remain the largest global market for cell and gene therapy manufacturing qc market.
- In Latin America, Rest of Latin America is projected to capture the leading share of market by 2028.
- Among Latin America markets, Mexico is expected to post the fastest growth, reaching USD 4707 Million by 2028.
Brazil Cell and Gene Therapy Manufacturing QC Market Revenue Share 2024
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope |
Details |
| Base Year for Study |
2024 |
| Study Period |
2021-2028 |
| Historical Period |
2021-2023 |
| Forecast Period |
2025-2028 |
| Market Size In 2024 |
USD 47.33 Million |
| Market Size In 2028 |
USD 108.35 Million |
| Largest segment |
Cell Therapy |
| Fastest segment |
Gene Therapy |
| Units |
Revenue in USD Million |
| CAGR |
23.1% (2025-2028) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Brazil Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments |
Sub Segments |
| Therapy Type |
- Cell Therapy
- Gene Therapy
|
| Cell Therapy |
- CAR-T
- CAR-NK
- B-Cell
- Other
|
| CAR-T |
- Autologous CAR-T
- Allogeneic CAR-T
|
| Gene Therapy |
- Viral
- Non-Viral
|
| Viral |
- AAV
- Lentiviral vectors
- Other
|
| Scale |
- Pre commercial/ R&D Manufacturing
- Commercial Scale Manufacturing
|
| Mode |
- Contract Manufacturing
- In-house Manufacturing
|
| Workflow |
- Cell Processing
- Cell Banking
- Fill & Finish Operations
- Raw Material Testing
- Vector Production
- Other Workflows
|
| Process |
- Upstream Processes
- Downstream Processes
|
| End User |
- Pharmaceutical Companies
- Biopharmaceutical / Biotechnological Companies
- Contract Manufacturing Organizations
|
| Pharmaceutical Companies |
- Small Size
- Medium Size
- Large Size
|
| Biopharmaceutical / Biotechnological Companies |
- Small Size
- Medium Size
- Large Size
|
| Contract Manufacturing Organizations |
- Small Size
- Medium Size
- Large Size
|
| Technology Type |
- Fluorescence-Activated Cell Sorting (FACS)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chromatography
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- OthersÂ
|
Brazil Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.